Fetal alcohol spectrum disorder and ADHD: diagnostic implications and therapeutic consequences

References

• Lemoine P, Harousseau H, Borteyru JR Les enfants de parents alcoholiques, anomalies observees a propos de 127 cas. Quest. Med 21,476–482 (1968).
   Google Scholar
• Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet2, 999–1001 (1973).
   Web of Science ®Google Scholar
• Streissguth AP O'Malley KD. Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Sem. Clin. Neumpsychiatry5, 177–189 (2000).
   Google Scholar
• Kapp FME, O'Malley KD. Watch for the Rainbows. True Stories for Educators and Other Cairgivers of Chilthrn With Fetal Alcohol Spectrum Disorders Frances. Kapp Education, Calgary, France (2001).
   Google Scholar
• O'Malley KD, Streissguth AP. Clinical intervention and support for children aged zero to three with fetal alcohol spectrum disorder and their parents/ caregivers. In: Encyclopedia on Early Childhood Development. Centre of Excellence for Early Childhood Development Website, (2003). www.excellence-earlychildhood.ca
   Google Scholar
• •Most up-to-date paper reviewing the interventions and support for parents in population of children with fetal alcohol spectrum disorder under 5 years old.
   Google Scholar
• Sampson PD, Streissguth AP, Bookstein FL et al Incidence of fetal alcohol syndrome and the prevalence of alcohol related neurodevelopmental disorder. TiTatology56, 317–326 (1997).
   PubMed Web of Science ®Google Scholar
• Bookstein FL, Streissguth AP, Sampson PD et al. Corpus callosum shape and neuropsychological deficits in adult males with heavy fetal alcohol exposure. Alcohol Clin. Exp. Res. 23, 28A (1999).
   Google Scholar
• Bookstein FL, Sampson PD, Streissguth AP, Connor PL. Geometric morphometrics of corpus callosum and subcortical structures in fetal alcohol affected brain. Teratology 4,4–32 (2001).
   Google Scholar
• Bookstein FL, Sampson PD, Connor PD, Streissguth AP. Midline corpus callosum is a neuroanatomical focus of fetal alcohol damage. Anat. Rec. New Anat). 269,162–174 (2002).
   PubMedGoogle Scholar
• Li TK. Pharmacogenetics of response to alcohol and genes that influence alcohol drinking. j Stud. Alcohol 61,5–12 (2000).
   PubMed Web of Science ®Google Scholar
• Jones KL. From Recognition to Responsibility Josef Warkany, David Smith and the Fetal Alcohol Syndrome in the 21st Century, 2002. Warkany Lecture, Birth Defects Research (Part A). 67, 13–20 (2003).
   PubMedGoogle Scholar
• O'Malley KD, Nanson J. Clinical implications of a link between fetal alcohol spectrum disorder and attention deficit hyperactivity disorder. Can.j Psychiatry 47 (4), 349–354, (2002).
   Google Scholar
• ••Recent article on the link betweenfetal alcohol spectrum disorderand attention deficit hyperactivity disorder.
   Google Scholar
• Allen AJ. ADHD, phenotypes and pathophysiologies, advanced studies in medicine, Johns Hopkins University. 2(25), 906–909 (2002).
   Google Scholar
• Amen DG. BrainPlace.com. ADD Subtype Checklist, the Amen Clinic for Behavioral Medicine (2002–2003).
   Google Scholar
• Biederman J, Newcom J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depression, anxiety and other disorders. Am. Pwchiatry148,564 (1991).
   Google Scholar
• O'Malley KD. Youth with comorbid disorders. In: The Handbook of Child and Adolescent Systems of Care. Pumariega AJ, Winters NC, (Eds). JosseyBass Publishers, CA, USA 276–315 (2003).
   Google Scholar
• O'Connor DE, Edwards G, Fletcher KE, Baird J, Barkley RA, Steingard RJ. Correlates of comorbid psychopathology in children with ADHD, jAm. Acad. Child Adolesc. Psychiatry 42(2), 193–200 (2003).
   Google Scholar
• Sulik KK, Johnson MC Webb MA. Fetal alcohol syndrome, embryogenesis in a mouse model. Science 214,936–938 (1981).
   PubMed Web of Science ®Google Scholar
• Abel EL. Fetal Alcohol Syndrome and Fetal Alcohol Effects. Plenum Press, NY, USA (1984).
   Google Scholar
• Nanson JL, Hiscock M. Attention deficits in children exposed to alcohol prenatally. Alcohol Clin. Exp. Res. 5,656–661 (1991).
   Google Scholar
• Driscoll CD, Streissguth AP, Riley ER Prenatal alcohol exposure, comparability of effects in humans and animal models. Neurotoxicol 7eratol 12,231–237 (1991).
   Google Scholar
• Hannigan JH, Randall S. Behavioral pharmacology in animals exposed prenatally to alcohol. In: Fetal Alcohol Syndrome, From Mechanism to Prevention. Abel EL (Ed.). CRC Press, NY, USA 191–213 (1996).
   Google Scholar
• O'Malley KD, Hagerman RJ. Developing clinical practice guidelines for pharmacological interventions with alcohol-affected children. In: Intervening With Children Affected By Prenatal Alcohol Exposure. Proceedings of a special focus session of the interagency co-ordinating committee on fetal alcohol syndrome Chevy Chase (MD). Centers for Disease Control and Prevention (Eds). National Institute on Alcohol Abuse and Alcoholism, USA, 145–177 (1998).
   Google Scholar
• ••Best overview article on pharmacologicalmanagement of children and adolescents with fetal alcohol spectrum disorder.
   Google Scholar
• Streissguth AP, Barr HM, Kogan J, Bookstein FK. Understanding the occurrence of secondary disabilities in clients with fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE). Final report to Centres for Disease Control and Prevention. Seattle, WA, University of Washington, Fetal Alcohol and Drug Unit. Tech. Report. 96(0), (1996).
   Google Scholar
• Coggins TE, Friet T, Morgan T Analyzing narrative productions in old school-age children and adolescents with fetal alcohol syndrome, an experimental tool for clinical applications. Clin. Ling. Phonet. 12,221–236 (1998).
   Web of Science ®Google Scholar
• Glaser D. Child abuse and neglect and the brain — a review. j Child Psy Bychiatry 41, 97–116 (2000).
   PubMed Web of Science ®Google Scholar
• ••Important current review paper on theinteraction between child abuse/neglect and the brain.This is of critical importance to fetal alcohol spectrum disorder population.
   Google Scholar
• Murray JR Blain Structure Difference Linked to Disruptive Teens. Radiological Society of North America (RSNA). Paper presentation, 2nd December (2002).
   Google Scholar
• Bauer LO, Hesselbrock VM. Brain maturation. Subtypes of conduct disorder, interactive effects on p300 amplitude and topography in male adolescents. J Am. Acad. Child Adolesc. Fiychiatry 42(1), 106–115 (2003).
   Google Scholar
• Giancola PR, Zeichner. A neuropsychological performance on tests of frontal lobe functioning and aggressive behavior in males. J Abnorm. Psychol. 103, 832–835 (1994).
   PubMed Web of Science ®Google Scholar
• Goodman R. The relationship between normal variation in IQ and common childhood psychopathology, a clinical study. Eur. Child Adolesc. Fiychiat. 4, 187–196 (1995).
   PubMed Web of Science ®Google Scholar
• Stratton KR, Howe CJ, Battaglia PC. Fetal Alcohol Syndrome, Diagnosis, Epidemiology Prevention and Treatment. Institute of Medicine, Medicine. National Academy Press, Washington DC, USA (1996).
   Google Scholar
• •Institute of Medicine's definitive book which describes the fetal alcohol spectrum disorder subtypes.
   Google Scholar
• Stromland KK, Pinazo-Duran MD. Optic nerve hypoplasia, comparative effects in children and rats exposed to alcohol during pregnancy. TiTatology50, 100–111, (1994).
   PubMedGoogle Scholar
• Droesti IE. Nutritional factors underlying the expression of the fetal alcohol syndrome. In: Maternal Nutrition and Pregnancy Outcome. Keen Cl, Bendich A, Willhite CC, (Eds). Ann. NY Acad. Sci. 678, 193–204 (1993).
   Google Scholar
• •Most complete analysis of nutritional factors related to fetal alcohol spectrum disorder.
   Google Scholar
• Tanner EM, Finn-Stevenson M. Nutrition and brain development, social policy implications, Am. J Chihopsychiatry72 (2), 182–193 (2002).
   PubMed Web of Science ®Google Scholar
• Meyers A, Chawla N. Nutrition and the social, emotional and cognitive development of infants and young children zero to three. 21(1), 5–12 (2000).
   Google Scholar
• Jameson S. Zinc status in pregnancy, the effect of zinc therapy on perinatal mortality, prematurity and placental ablation. In: Maternal Nutrition and Prrgnancy Outcome. Keen CL, Bendich A, Willhite CC (Eds). Ann. NY Acad. Li. 678, 178–192 (1993).
   Google Scholar
• Arnold E, Jensen PS. Attention deficit disorders. In: Comprehensive Textbook of Psychiatry 6th Edition. Sadock, Yudofsky (Eds). 2, 2295–2310 (1995).
   Google Scholar
• Pliszka SR, Mc Cracken JT, Maas JW. Catecholamines in attention deficit hyperactivity disorder. Current perspectives. J. Af17. Arad Child Adolesc. Fiychiatry35, 264–272 (1996).
   Google Scholar
• Castellanos FX. Toward a pathophysiology of attention deficit/hyperactivity disorder. Clin. Paeckr 3, 381–395 (1997).
   Google Scholar
• Cyr M, Brown CS, Current drug therapy recommendations for the treatment of ADHD. Drugs 56, 215–222 (1998).
   PubMed Web of Science ®Google Scholar
• Stevenson J. Evidence for a genetic etiology in hyperactivity in children. Behar/. Genet. 22, 337–343 (1992).
   PubMed Web of Science ®Google Scholar
• Cook EH, Stein MA, Krasowski MD. Association of attention deficit disorder and the dopamine transporter gene. Am. J Hum. Genet. 56, 993–998 (1995).
   PubMed Web of Science ®Google Scholar
• Eaves LG, Silberg JL, Meyer JM. Genetics and developmental psychopathology 11, the main effects of gene and environment on behavioral problems in the Virginia twin study of adolescent behavioral development J. Child Bychol. Psychiatry38, 965–980 (1997).
   Google Scholar
• Waldman I. Transmission disequilibrium tests of the association of DRD4 and DAT to symptoms of ADHD. Presented at World Congress of Psychiatric Genetics, Santa Fe, NM, USA (1997).
   Google Scholar
• Druse MJ. Effects of maternal alcohol on the developing nervous system. In: Alcohol, and Neurobiology Brain Development and Hormone Regulation. Watson RR, (Ed.) CRC Press, NY, USA (1992).
   Google Scholar
• Maneuffel MD. Neurotransmitter function, changes associated with in utem alcohol exposure. In: Fetal Alcohol Syncivme, From Mechanism to Prevention. Abel EL (Ed.). CRC Press, NY, USA, 171–189, (1997).
   Google Scholar
• Tomkins DM, Sellers EM Addiction and the brain, the role of neurotransmitters in the cause of drug dependence. CM4J20, 164(6), 817–821 (2001).
   Google Scholar
• Rich D, Barone S. Critical periods of vulnerability for the developing nervous system, evidence from humans and animal models, environmental health perspectives. 108 (Suppl. 3), 515–533 (2000).
   Google Scholar
• Thompson RA, Nelson CA. Developmental science and the media. Am. Psychologist January, 5–15 (2001).
   Google Scholar
• Hagerman RJ. Neurodevelopmental Disorrlers. Diagnosis and Treatment. Oxford University Press, NY, USA, Oxford, UK (1999).
   Google Scholar
• O'Malley KD. Update on the role of medication in treating patients with FASD. Iceberg10 (3), 4–5 (2000).
   Google Scholar
• Russell O. Seminars. In: The Psychiatry of Learning- Disabilities. Royal College of Psychiatrists, USA, Chapters 4,5,8,10 and 20 (1997).
   Google Scholar
• Synder J, Nanson J, Synder R, Block G. A study of stimulant medication in children with FAS. In: The Challenge of Fetal Akohol Syndrome. Overcoming Secondary Disabilities. Streissguth AP, Kanter J (Eds). University of Washington Press, WA, USA, 64–77, (1997).
   Google Scholar
• Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson A, Fiechtner H. Effectiveness of methylphenidate in native american children with fetal alcohol syndrome and attention deficit/hyperactivity disorder, a controlled pilot study. J. Child Adol. Psychopharm. 8(1), 39–48 (1998).
   Google Scholar
• O'Malley KD, Koplin B, Dohner VA. Psychostimulant clinical response in fetal alcohol syndrome. Can. J Psychiatry 45(1), 90–91 (1999).
   Web of Science ®Google Scholar
• Coe JA, Sidders J, Riley K, Waltermire J, Hagerman RJ. A survey of medication response in children and adolescents with fetal alcohol syndrome. In: Nerodevelopmental Disarlers. Hagerman RJ (Ed.). Oxford University Press, Oxford, USA (1999).
   Google Scholar
• Patrick KS, Caldwell RVV, Ferris RM, Breese GR. Pharmacology of the enantiomers of threomethylphenidate. Pharm. Exp. Ther. 241, 152–158 (1987).
   PubMed Web of Science ®Google Scholar
• Faraj BA, Israili ZH, Perel JM et al Metabolism and disposition of methylphenidate- 14 C studies in man and animals. Pharm. Exp. Ther. 191, 535–547 (1974).
   Google Scholar
• Srinivas NR, Quinn D, Hubbard JVV, Midha KK. Enatioselective pharmacolkinetics and pharmacodynamics of dl-threo methylphemdate in children with attention deficit hyperactivity disorder. Glitz Pharmacol. Then 52, 561–568 (1987).
   Google Scholar
• Shaywitz SE, Hunt RD, Jatlow P etal. Psychopharmacology of attention deficit disorder. Pharmacolkinetic, neuroendocrine and behavioral measures following acute and chronic treatment with methylphenidate. Pediatrics69, 688–694 (1982).
   Google Scholar
• Gualtieri CT, Hicks RE, Patrick K, Schroeder SR, Breese GR. Clinical correlates of methylphenidate blood levels. Ther. Drug Monitor 6, 379–392 (1984).
   PubMed Web of Science ®Google Scholar
• Sebrechts MM, Shaywitz SE, Shaywitz BA, Jatlow P, Anderson GA, Cohen DJ. Components of attention, methylphenidate dosage and blood levels in children with attention deficit disorder. Pediatrics 77, 222–228 (1986).
   PubMed Web of Science ®Google Scholar
• Winsberg BG, Kupietz SS, Sverd J, Hungund BL, Young NL. Methylphenidate oral dose plasma concentrations and behavioral response in children. Pharm. Bull. 23, 107–110 (1982).
   Google Scholar
• Kollins SH, Mac Donald EK, Rush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects, a review. Pharmacol Biochem. Behar/. 68,611–627 (2001).
   PubMed Web of Science ®Google Scholar
• Challman TD, Lipksy JJ. Methylphenidate, its pharmacology and uses. Nityo Gun. Proc. 75,711–721 (2000).
   PubMed Web of Science ®Google Scholar
• Klein-Schwartz W, Mc Grath J. Poison Center's experience with methylphenidate abuse in teens and preteens and adolescents. A117. Acad. Child Adolesc. Psychiatry43(3), 288–294 (2003).
   Google Scholar
• Saunders L. The Absorption and Distribution of Drugs. William and Williams, Baltimore, MD, USA, 141–153 (1974).
   Google Scholar
• Shiyama S, Soejima-Ohkuma T, Honda S et al. Major role of the CYP2C isoenzymes in deamination of amphetamine and bezphetamine, evidence for the quinidine-specific inhibition of the reactions catalyzed rabbit enzyme. Xenobiotica 27,379–387 (1997).
   PubMed Web of Science ®Google Scholar
• Bach MV, Coutts RT, Baker GB. Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamine and their 4-methoxylated derivatives. Xenobiotica 7, 719–732 (1999).
   Google Scholar
• The Biochemical Basis of Neuropharmacology 8th Edition. Cooper JR, Bloom FE, Roth RE (Eds). Oxford University Press, Oxford, UK (2003).
   Google Scholar
• •Essential textbook reading for basic understanding of neuropharmacolgy, most recent edition.
   Google Scholar
• Biederman J, Loez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of 5LI381 (Adderall XR) in children with attention deficit hyperactivity disorder. Pediatrics 110 (2), 258–273 (2002a).
   Google Scholar
• Tulloch SJ Zhang Y, Mc Lean A, Wolf KN SLI 381 (Adderall XR), a two component, extended-release formulation of mixed amphetamine salts, bioavailability of three test formulations and comparison of fasted, fed and sprinkled administration. Pharmacotherapy 11, 1405–1415 (2002).
   Google Scholar
• Kractochvil CJ. New ADHD treatment options on the horizon. Adv. Stud. Med. 2(25), 915–918 (2002).
   Google Scholar
• Eli Lilly Co., IN, USA. Strattera package information (2002).
   Google Scholar
• O'Malley KD. Medication therapy's role for FAS. Iceberg 7(4), 1,3-4 (1997).
   Google Scholar
• Diagnostic and Statistical Manual of Mental Disotylers, 4th edition, (DSM IV), American Psychiatric Association, Washington DC, USA, 74–85 (1994).
   Google Scholar
• American Academy of Pediatrics (AAP). Clinical Practice Guidelines, Diagnosis and evaluation of the child with attention deficit hyperactivity disorder. Pediatrics 105(5), 1158–1170 (2000).
   PubMed Web of Science ®Google Scholar
• ••Current American Academy of Pediatricsguidelines on diagnosis of attention deficit hyperactivity disorder.
   Google Scholar
• Biederman J. Practical considerations in stimulant drug selection for the attention-deficit hyperactivity disorder patient efficacy, potency and titration. Todays' Therapeutic Bends 20(4), 311–328 (20020.
   Google Scholar
• ••Recent clinical review article onpharrnacotherapy of attention deficit hyperactivity disorder by a well-respected international expert.
   Google Scholar
• Zero to Three. National Center for Infants, Toddlers and Families. 5th Printing, 734 15th Street NW, Suite 1000, Washington, DC USA, 20005–1013 (1999). soThomas A, Chess S. Temperament and Development. BrunneriMazel, NY, USA (1977).
   Google Scholar
• O'Malley KD. Temperament and attachment issues in fetal alcohol spectrum disorder, children's mental health — a systems of care approach. Paper presentation, AACAP, Portland, OR, USA, August 3rd (2001).
   Google Scholar
• Havicek V, Childiaeva R, Chemick V. EEG frequency characteristics of sleep states in infants of alcoholic mothers. Neuropaediatrie 8,360–373 (1977).
   Google Scholar
• Storoz L. Personal communication, (2003).
   Google Scholar
• Martin KR. Prenatal exposure to methamphetamine increases the vulnerability to the drug's neurotoxic effects in adult male mice. MDA Notes17(2), 11–12 (2001).
   Google Scholar
• Mezzacappa E, Kindlon D, Earls E Relations of age to cognitive and motivational elements of impulse control in boys with and without externalizing behavior problems. j Abnor. Child Ptychol 27,473–483 (1999).
   PubMed Web of Science ®Google Scholar
• Huggins JE, Connor PD, O'Malley KD, Barr HM, Streissguth AR Suicidal behavior in fetal alcohol spectrum disorders (FASD). Proceedings of the 24th Scientific Meeting- of the Research Society of Alcohol. Montreal, Canada, Abstract June (2001).
   Google Scholar
• O'Malley KD, Barr H. Fetal alcohol syndrome and seizure disorder. Can. Psychiatry 43(10), 1051 (1998).
   PubMed Web of Science ®Google Scholar
• Barnard KE. Keys to Care-Giving. Self instructional video series. Available from NCAST Publications, University of Washington, Center for Human Development and Disabilities, Seattle, WA, USA, 98,7195–7920 (1990).
   Google Scholar
• Jirikowic T Sensory integration for children with prenatal alcohol exposure. Iceberg 10(3), 1–2 (2000).
   Google Scholar
• Pumariega AP, Fallon T Pharmacotherapy in systems of care for mental health. In: The Handbook of Child and Adolescent Systems of Care. The New Community Psychiatry Jossey-Bass, CA, USA, 120–148 (2003).
   Google Scholar
• Koob GF, Weiss F. Neuropharmacology of cocaine and ethanol dependence. In: Rettyrt Developments in Alcoholism Galanter M, (Ed.). Plenum Press, NY, USA, 10,201-233 (1992).
   Google Scholar
• Tarter R, Vanyukov M, Dawes M, Blackson T, Mezzich A, Clark DB. Etiology of early onset substance use disorder, a maturational perspective. 11,657–683 (1999).
   Google Scholar
• Grant TM, Ernst CC, Streissguth AR Intervention with high-risk alcohol and drug abusing mothers, 1. Administrative strategies of the Seattle Model of Paraprofessional Advocacy J. Com. Psycho" 27,1–18, (1999).
   Google Scholar
• Ernst CC, Grant TM, Streissguth AP, Sampson PD. Intervention with high risk alcohol and drug abusing mothers, II Three year findings from the Seattle Model of Paraprofessional Advocacy. J. Com. Bychol. 27,19–38 (1999).
   Web of Science ®Google Scholar
• Shire US, Inc., Florence, KY, USA. Adderall XR package insert (2001).
   Google Scholar
• Celltech pharmaceuticals, Inc., Rochester, NY, USA. Metadate CD package insert (2002).
   Google Scholar
• Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. Ritalin-LA package insert (2002).
   Google Scholar